Schedule 13D ownership disclosure

POINT BIOPHARMA GLOBAL INC

Security class unavailable · CUSIP: 730541109

Event date: 2021-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-091198
Form type
SC 13D
Filer
POINT Biopharma Global Inc.
CIK
CIK 1811764
Filed
Jul 12, 2021
Reporting period
Jun 30, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub